New needle-free alternative to the epipen could help kids
The FDA approved Neffy for adults and children weighing at least 66 pounds who are in danger of anaphylaxis. It contains the same medication as the EpiPen, delivered through the nose.
Watch CBS News
The FDA approved Neffy for adults and children weighing at least 66 pounds who are in danger of anaphylaxis. It contains the same medication as the EpiPen, delivered through the nose.
The FDA says four or five cups a day is safe to drink, but overuse can lead to insomnia, jitters, anxiousness, upset stomach, and headaches.
The FDA found even some products that claimed to be "sterile" were contaminated.
It affects almost seven million Americans. It will be sold under the brand name Kisunla. It's supposed to be for people with very early onset symptoms and used through monthly infusions.
It works by helping the body remove a certain type of plaque in the brain associated with Alzheimer's. The drug is not a cure, but clinical trials showed it slowed the progression of the disease.
Last year, the Food and Drug Administration lifted rules put in place in the 80s during the AIDS/HIV crisis.
The court said the plaintiffs lacked standing to bring the case. A group of doctors opposed to abortions sued the FDA after it eased restrictions on the pill, mifepristone, making it more readily accessible.
It's called TIL therapy, and it recently received FDA approval. CBS's Michael George introduces us to one patient who participated in clinical trials.
Health officials are warning consumers not to consume Infinite Herbs basil sold at some Trader Joe's and Dierberg's stores after 12 people were sickened.
Supreme Court justices heard arguments on Tuesday about access to abortion medication. At issue is whether the Food and Drug Administration properly considered safety when it expanded access to a pill commonly used for the procedure.
Reproductive rights groups in Chicago planned to picket outside the Dirksen Federal Courthouse downtown on Tuesday, as the battle over abortion returns to the U.S. Supreme Court, where justices heard arguments on a case involving the FDA's approval and regulations for the use of mifepristone.
This week, abortion access returns to the U.S. Supreme Court, nearly two years after the nation's highest court overturned the landmark Roe v Wade decision. This time access to the abortion pill mifepristone hangs in the balance in a case from Wisconsin.
The Great Value Honey Roasted Cashews have been recalled due to unknown milk and coconut allergens, according to a company statement posted by the Food and Drug Administration.
In January, the FDA changed regulations to allow retail pharmacies to sell the drug mifepristone.
Multiple brands sold by Walmart and CVS recalled as FDA cites unsterile conditions at Indian manufacturing plant.
Ecuador's authorities allege that Carlos Aguilera, a cinnamon grinder in that country, is "the likely source" of the contaminated spices that led to the recall of WanaBana applesauce.
FDA testing found "extremely high levels of lead contamination" in the cinnamon applesauce pouches, which have been recalled.
Quaker Oats expands prior recall to include more granola bars, cereals and a snack mix possibly tainted with bacteria.
CDC investigating fruit from HMC Farms after one person died and 10 are hospitalized following a listeria outbreak.
Kilitch Healthcare India is recalling the products more than three weeks after the FDA warned against their use.
The latest recall includes drops sold at stores including CVS, Rite Aid, Target, and Walmart.
The latest recall includes drops sold at stores including CVS, Rite Aid, Target, and Walmart. The FDA has cited a risk of eye infections that could result in partial vision loss or blindness.
Many popular diet sodas, light gelatins and sugar-free gums contain the artificial sweetener.
The U.S. Food and Drug Administration approved the first over-the-counter birth control pill, allowing Americans to buy Opill, a daily oral contraceptive, without a prescription.
"The estimated cost of the drug is thought to be about around $26,000 a year."